[144] INCYTE CORP SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Incyte Corp (INCY) discloses a proposed sale of 278 common shares by an insider through Morgan Stanley Smith Barney on 09/16/2025 with an aggregate market value of $23,115.70 and total shares outstanding listed as 195,276,145. The shares were acquired and paid for on 09/16/2025 via a stock option exercise with cash payment. The filer also reported six prior sales by the same person between 07/02/2025 and 09/02/2025, totaling 6,187 shares and gross proceeds shown for each trade.

Positive

• Full compliance with Rule 144 disclosure requirements including acquisition, payment method, broker, and sale dates
• Transparent history of recent insider sales with gross proceeds disclosed for each trade

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider exercised options and is selling a small position relative to outstanding shares; recent repeated sales suggest ongoing liquidity events.

The filing shows a routine Rule 144 notice where the insider exercised options and immediately plans to sell 278 shares for $23,115.70 on 09/16/2025. Prior transactions from 07/02/2025 to 09/02/2025 indicate six sales totaling 6,187 shares, with gross proceeds disclosed per trade. Relative to the 195.3 million shares outstanding, these volumes are immaterial to market supply. This pattern is consistent with option exercise monetization rather than a material change in company fundamentals.

Corporate Governance Expert

TL;DR: Multiple small insider disposals are disclosed correctly under Rule 144; filings include required representations and signature warnings.

The notice includes the required representations that the seller is not aware of undisclosed material adverse information and documents acquisition details (exercise date and cash payment). Sales were routed through a registered broker-dealer and the filing lists dates and proceeds for recent transactions, meeting disclosure norms. There is no indication in the form of undisclosed related-party transactions or anomalous payment terms.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	278	23115.70	195276145	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2025	Stock Option Exercise	ISSUER			278	09/16/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	09/02/2025	598	50812.06
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	08/15/2025	277	24046.37
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	08/04/2025	598	45310.46
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/16/2025	785	53662.60
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/15/2025	3330	232633.80
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/02/2025	599	41097.39

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the INCY Form 144 filed on 09/16/2025 disclose?

The filing discloses a proposed sale of 278 common shares by an insider through Morgan Stanley on 09/16/2025 with an aggregate market value of $23,115.70.

How were the 278 INCY shares acquired according to the filing?

The shares were acquired on 09/16/2025 by stock option exercise and paid for in cash on the same date.

Who is the broker handling the proposed INCY sale?

The sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.

What prior insider sales by the same person are disclosed?

Six prior sales between 07/02/2025 and 09/02/2025 are listed, totaling 6,187 shares with individual gross proceeds reported per trade.

Do these sales materially affect INCY's share count?

No; the disclosed trades are small relative to the reported 195,276,145 shares outstanding, so they are not material to total share count.